Objectives
Plasma lipoprotein profile is one of the major factors to describe the risk of atherosclerotic cardiovascular disease. The exact mechanisms for development and progression of atherosclerosis in subjects with coronary artery disease (CAD) although having higher HDL-C levels are still unknown. To reveal the role of CETP activity and mass levels in the atherosclerotic process is very important for these subjects. The aim of our study is to compare the levels of CETP mass and activity between the patients with coronary artery disease and healthy subjects, although having higher HDL-C levels.
Methods
Between April 2011 and May 2013 50 patients who have coronary artery disease and HDL-C levels >= 60 mg/dl, LDL-C levels >=130 mg/dl, and 50 healthy subjects with the same lipid profile who admitted Gazi University Cardiology Department, enrolled for this study. The CETP mass and activity levels of the patients and control subjects were measured.
Methods
Between April 2011 and May 2013 50 patients who have coronary artery disease and HDL-C levels >= 60 mg/dl, LDL-C levels >=130 mg/dl, and 50 healthy subjects with the same lipid profile who admitted Gazi University Cardiology Department, enrolled for this study. The CETP mass and activity levels of the patients and control subjects were measured.
Stay updated, free articles. Join our Telegram channel
Full access? Get Clinical Tree
